Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (481-490 of 509) with videos related to

Pageof 51
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2020
Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?Georgia Vourli, Teymur Noori, Anastasia Pharris, et al.
ACS Nano|September 3, 2025
Prospects of Nanoscience with Nanocrystals: 2025 EditionMaria Ibáñez, Simon C Boehme, Raffaella Buonsanti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2015
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries, Lauren E Cain, Andrew Phillips, et al.
Plos Biology|July 14, 2017
Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in EuropeFrançois Blanquart, Chris Wymant, Marion Cornelissen, et al.
American Journal of Epidemiology|May 8, 2019
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With ApplesSara Lodi, Andrew Phillips, Jens Lundgren, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 2, 2015
Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013, Amanda Mocroft, Jens Lundgren, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 12, 2018
Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral TherapyLuuk Gras, Margaret May, Lars Peter Ryder, et al.
Virus Evolution|June 8, 2018
Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiverChris Wymant, François Blanquart, Tanya Golubchik, et al.
Medicine|October 15, 2016
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individualsLauren E Cain, Ellen C Caniglia, Andrew Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
Pageof 51

Showing results (481-490 of 509) with videos related to

Sort By:
Pageof 51
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2020
Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?Georgia Vourli, Teymur Noori, Anastasia Pharris, et al.
ACS Nano|September 3, 2025
Prospects of Nanoscience with Nanocrystals: 2025 EditionMaria Ibáñez, Simon C Boehme, Raffaella Buonsanti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2015
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries, Lauren E Cain, Andrew Phillips, et al.
Plos Biology|July 14, 2017
Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in EuropeFrançois Blanquart, Chris Wymant, Marion Cornelissen, et al.
American Journal of Epidemiology|May 8, 2019
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With ApplesSara Lodi, Andrew Phillips, Jens Lundgren, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 2, 2015
Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013, Amanda Mocroft, Jens Lundgren, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 12, 2018
Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral TherapyLuuk Gras, Margaret May, Lars Peter Ryder, et al.
Virus Evolution|June 8, 2018
Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiverChris Wymant, François Blanquart, Tanya Golubchik, et al.
Medicine|October 15, 2016
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individualsLauren E Cain, Ellen C Caniglia, Andrew Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
Pageof 51